1. Home
  2. Pharma and Healthcare

Category: Pharma and Healthcare

ARX Equity Partners makes 3.6x return on healthcare business sale

ARX acquired DCB in 2015 and said it has doubled the company’s revenue during the holding period

Ontario pension plan’s private equity investments boost 2019 returns

Healthcare of Ontario Pension Plan’s private equity portfolio has shifted focus to co-investments and direct investments

PE-owned UK care homes under the spotlight amid coronavirus pandemic

Buyout firms have targeted the care home sector in the past decade but concerns have been raised about hygiene and health standards

Covid-19 halts CapVest’s €3bn sale of Curium Pharma

The company said it will reassess the situation and the strategic options for the business in due course

Opalesque Exclusive: Healthcare private equity posts highest ever deal value in 2019

Bailey McCann, Opalesque New York: Healthcare private equity had a robust 2019. Total disclosed deal value reached $78.9 billion, the highest on record, and the deal count of 313 was in line with the 316

AMB :- Opalesque Exclusive: Healthcare private equity posts highest ever deal value in 2019

Bailey McCann, Opalesque New York: Healthcare private equity had a robust 2019. Total disclosed deal value reached $78.9 billion, the highest on record, and the deal count of 313 was in line with the 316

Growing popularity of healthcare expected to continue, says Bain

Private equity firms see the sector as a place of steady returns in periods of global economic instability

EIB loans Italy €2bn for healthcare

Italy will receive a €2bn loan from the European Investment Bank to help cover the reinforcement of its healthcare system required to deal with the coronavirus pandemic.

Grand Pharmaceutical pockets HK$1bn from share sale

China Grand Pharmaceutical and Healthcare Holdings has tapped the equity capital market for HK$1.01bn ($130.9m), boosting its share price over 20% as a result.

CDR bids for Huntsworth in mid-market take-private

Clayton, Dubilier & Rice has launched a take-private bid for UK based healthcare marketing and PR firm Huntsworth, bidding an enterprise value of £524m for the company. The debt financing for the deal is a

Clayton Dubilier & Rice to take UK’s Huntsworth private in £400m deal

The healthcare communications agency's share price surged 51% following the news

US Democrats target private equity-owned hospitals with transparency bill

The House Ways and Means Committee passed a bill that would expand financial disclosures by health providers backed by private equity

KKR forms $200m biosciences investment platform

The platform has already announced two deals, which are the first European investments from the $1.45bn Healthcare Strategic Growth fund

Opalesque Exclusive: Optima A.M. bets on healthcare and biotech innovations with long/short strategy

B. G., Opalesque Geneva: Optima Asset Management has just launched the Optima Healthcare and Biotechnology strategy, which will be managed by five portfolio managers, each specialising in a branch of the sector...Article Link

AMB :- Opalesque Exclusive: Optima A.M. bets on healthcare and biotech innovations with long/short strategy

B. G., Opalesque Geneva: Optima Asset Management has just launched the Optima Healthcare and Biotechnology strategy, which will be managed by five portfolio managers, each specialising in a branch of the sector. The U...Article Link

China Resources Mixc eyes top pricing

China Resources Mixc Lifestyle Services, the property management business of state-owned developer China Resources Land, is set to price its HK$12.3bn ($1.58bn) Hong Kong IPO at the top end of guidance.

Baker Bros bags $340m from BeiGene block

Baker Bros Advisors, a shareholder in Chinese biopharmaceutical company BeiGene, has raised $340.1m from a sell-down of the firm’s American depositary shares.

JD Health prices HK$27bn IPO high on strong investor support

JD Health International has bagged HK$27bn ($3.5bn) after sealing its IPO at the top end of the marketed range, following a flood of global investor demand.

Partners Group-backed PCI Pharma weighs a sale

PCI Pharma Services is being marketed heavily to private equity buyers

Short-selling target NMC confirms KKR and GK Investment bid approaches

NMC Health’s shares spiked almost 12% after the troubled healthcare operator said it had received potential takeover offers

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.